share_log

領航醫藥生物科技:通函之補充公告有關 (1) 修訂可換股債券之條款及條件; (2) 授出特別授權發行換股股份; (3) 附屬公司層面之關連交易;及 (4) 股東特別大會通告

INNOVATIVE PHAR: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE CIRCULAR IN RESPECT OF (1) AMENDMENT OF THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS; (2) GRANT OF SPECIFIC MANDATE TO ISSUE CONVERSION SHARES; (3) CONNECTED TRANSACTION AT SUBSIDIARY LEVEL

香港交易所 ·  Jun 14, 2023 10:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more